"Canada Pharmaceuticals & Healthcare Report Q2 2013" Now Available at Fast Market Research
Innovative drugmakers have experienced increasing government cost containment pressure and generic competition in Canada. Local authority has also switched to more direct incentive to encourage R&D investment from pharmaceutical industry. We expect the country's relatively high generic drug price will fall further which will ultimately benefit consumers.
View full press release